Jaundice - Surgery MBBS Overview

Jaundice (icterus) is yellow discoloration of skin, sclera, and mucous membranes due to hyperbilirubinemia (clinically visible when serum bilirubin > 2-3 mg/dL). For surgery, the focus is mainly obstructive (surgical) jaundice - its causes, workup, and management - though you need the full classification to reason through a case.

Topic Breakdown

Bilirubin physiology and classification of jaundice - prehepatic (hemolytic), hepatic (hepatocellular), posthepatic (obstructive/cholestatic); unconjugated vs conjugated hyperbilirubinemia
Causes of surgical (obstructive) jaundice - choledocholithiasis, cholangiocarcinoma, carcinoma head of pancreas, periampullary carcinoma, benign biliary strictures, choledochal cyst, Mirizzi syndrome, biliary atresia, parasites
Clinical evaluation - history (pain vs painless, fever/Charcot's triad, pruritus, weight loss, stool/urine color), examination (palpable gallbladder - Courvoisier's law, hepatomegaly, signs of chronic liver disease)
Investigations - LFTs (conjugated vs unconjugated bilirubin, ALP, GGT, transaminase pattern), ultrasound, CT, MRCP, ERCP, PTC, tumor markers (CA 19-9, CEA), coagulation profile
Differentiating medical vs surgical jaundice - biochemical patterns, imaging findings
Preoperative preparation of a jaundiced patient - vitamin K, coagulopathy correction, hepatorenal syndrome/renal protection, hydration, prophylactic antibiotics, nutrition, management of coagulopathy and risk of postoperative complications
Management - endoscopic (ERCP with sphincterotomy/stenting), percutaneous (PTBD), surgical (choledochotomy, biliary-enteric bypass, Whipple's procedure), management of cholangitis
Complications of obstructive jaundice - cholangitis, hepatorenal syndrome, coagulopathy, impaired wound healing, endotoxemia
Postoperative jaundice - causes specific to surgical patients (hemolysis from transfusion, drug-induced, sepsis, benign postoperative cholestasis)

This is a broad surgical topic that combines physiology, clinical diagnosis, and operative/interventional management (a common viva and exam topic, especially "approach to a jaundiced patient" and "obstructive jaundice management").

Which topic would you like me to go deep into first?

Asking for Preferences

Which part of jaundice do you want to go deep into first?

Jaundice - Surgery MBBS Overview

Topic Breakdown

Bilirubin physiology and classification of jaundice - prehepatic (hemolytic), hepatic (hepatocellular), posthepatic (obstructive/cholestatic); unconjugated vs conjugated hyperbilirubinemia
Causes of surgical (obstructive) jaundice - choledocholithiasis, cholangiocarcinoma, carcinoma head of pancreas, periampullary carcinoma, benign biliary strictures, choledochal cyst, Mirizzi syndrome, biliary atresia, parasites
Clinical evaluation - history (pain vs painless, fever/Charcot's triad, pruritus, weight loss, stool/urine color), examination (palpable gallbladder - Courvoisier's law, hepatomegaly, signs of chronic liver disease)
Investigations - LFTs (conjugated vs unconjugated bilirubin, ALP, GGT, transaminase pattern), ultrasound, CT, MRCP, ERCP, PTC, tumor markers (CA 19-9, CEA), coagulation profile
Differentiating medical vs surgical jaundice - biochemical patterns, imaging findings
Preoperative preparation of a jaundiced patient - vitamin K, coagulopathy correction, hepatorenal syndrome/renal protection, hydration, prophylactic antibiotics, nutrition, management of coagulopathy and risk of postoperative complications
Management - endoscopic (ERCP with sphincterotomy/stenting), percutaneous (PTBD), surgical (choledochotomy, biliary-enteric bypass, Whipple's procedure), management of cholangitis
Complications of obstructive jaundice - cholangitis, hepatorenal syndrome, coagulopathy, impaired wound healing, endotoxemia
Postoperative jaundice - causes specific to surgical patients (hemolysis from transfusion, drug-induced, sepsis, benign postoperative cholestasis)

Which topic would you like me to go deep into first?

Finding Sources

Jaundice for Surgery - MBBS Level

1. Definition and Bilirubin Physiology

Jaundice (icterus) is the yellowish discoloration of skin, sclera, and mucous membranes caused by hyperbilirubinemia. It becomes clinically visible once serum bilirubin exceeds ~2-3 mg/dL (normal 0.3-1.2 mg/dL); sclera is affected first because of its high elastin content, which has affinity for bilirubin.

Bilirubin metabolism (Schwartz's Principles of Surgery, p. 848; Harrison's Principles of Internal Medicine):

Senescent RBCs are broken down in the reticuloendothelial system (spleen, liver, bone marrow) -> heme -> unconjugated (indirect) bilirubin.
Unconjugated bilirubin is water-insoluble, travels bound to albumin, and is taken up by hepatocytes.
In the liver, UDP-glucuronosyltransferase (UGT1A1) conjugates bilirubin with glucuronic acid -> conjugated (direct) bilirubin, which is water-soluble.
Conjugated bilirubin is excreted into bile -> duodenum -> converted by gut bacteria to urobilinogen (partly reabsorbed via enterohepatic circulation, partly oxidized to stercobilin, giving stool its brown color) and urobilinogen excreted in urine.

Fractionating total bilirubin into conjugated vs unconjugated is the first diagnostic step.

2. Classification of Jaundice

Type	Level of defect	Bilirubin pattern	Common causes
Prehepatic (hemolytic)	Excess bilirubin production	Unconjugated predominant	Hemolytic anemias (sickle cell, thalassemia, G6PD deficiency, malaria), ineffective erythropoiesis
Hepatic (hepatocellular)	Hepatocyte uptake/conjugation/excretion defect	Mixed, both raised	Viral hepatitis, alcoholic hepatitis, drug-induced liver injury, cirrhosis, Gilbert's/Crigler-Najjar/Dubin-Johnson syndromes
Posthepatic (obstructive/surgical)	Mechanical block to bile flow after conjugation	Conjugated predominant	Choledocholithiasis, carcinoma head of pancreas, cholangiocarcinoma, periampullary carcinoma, benign biliary stricture, Mirizzi syndrome, biliary atresia

Surgery focuses on obstructive jaundice - this is the "surgical jaundice" that requires intervention.

Causes of Extrahepatic Cholestasis (Current Surgical Therapy 14e, p. 970)

Malignant: cholangiocarcinoma, carcinoma head of pancreas, gallbladder carcinoma, ampullary carcinoma
Benign: choledocholithiasis, primary/secondary sclerosing cholangitis, benign biliary strictures (post-cholecystectomy), choledochal cyst, parasites (ascaris, liver flukes), hemobilia, pancreatic pseudocyst, chronic pancreatitis, duodenal diverticulum
Congenital: biliary atresia, Caroli's disease

3. Clinical Approach

History

Pain: Painful obstructive jaundice -> think stones (choledocholithiasis). Painless, progressive jaundice -> think malignancy (carcinoma head of pancreas, cholangiocarcinoma, ampullary growth) - classic teaching point.
Fever with rigors: suggests ascending cholangitis.
Pruritus: from bile salt deposition in skin, common in obstructive jaundice.
Urine and stool color: dark urine (bilirubinuria) and pale, clay-colored stools (absent stercobilin) indicate obstructive/conjugated hyperbilirubinemia.
Weight loss, anorexia: raises suspicion for malignancy.
History of gallstone disease, alcohol intake, blood transfusion, drug intake, contact with jaundiced persons, travel history.

Examination

Palpate the abdomen for:
- Courvoisier's Law: "In a patient with jaundice, if the gallbladder is palpably enlarged, the cause is unlikely to be a stone" - because chronically inflamed, stone-bearing gallbladders are usually fibrotic and cannot distend, whereas malignant obstruction (e.g., carcinoma of the pancreatic head) causes a distended, palpable, non-tender gallbladder (S Das Manual on Clinical Surgery; Harrison's - Choledocholithiasis).
  - Exceptions: double impaction (stone in cystic duct + another in CBD), Mirizzi syndrome.
- Hepatomegaly, splenomegaly, ascites (chronic liver disease/portal hypertension).
- Signs of chronic liver disease: spider nevi, palmar erythema, gynecomastia, caput medusae, flapping tremor.
Charcot's triad (RUQ pain + fever + jaundice) - classic for acute cholangitis; present in only ~70% of patients. Reynolds' pentad adds hypotension and altered mental status, indicating suppurative cholangitis (Sleisenger and Fordtran's; Current Surgical Therapy).

4. Investigations

Laboratory (Liver Function Tests)

Test	Obstructive pattern
Total/conjugated bilirubin	Markedly raised, conjugated fraction predominant
ALP (alkaline phosphatase)	Markedly raised (from biliary canalicular epithelium)
GGT	Raised, confirms hepatobiliary origin of raised ALP
AST/ALT (transaminases)	Normal or mildly raised (hepatocellular pattern dominant in hepatitis, not obstruction)
PT/INR	May be prolonged due to malabsorption of vitamin K (fat-soluble, needs bile salts for absorption)
Albumin	Usually normal in pure obstruction (long half-life; more reflective of chronic disease)

Tumor markers: CA 19-9 (pancreatic/cholangiocarcinoma), CEA - support but don't confirm malignancy.

Imaging (stepwise)

Ultrasound abdomen - first-line; detects dilated intra/extrahepatic ducts, gallstones, gallbladder distension, and level of obstruction.
CT abdomen (triple phase) - better for pancreatic/periampullary masses, staging malignancy, vascular involvement.
MRCP (Magnetic Resonance Cholangiopancreatography) - non-invasive, excellent ductal anatomy, stone/stricture localization.
ERCP (Endoscopic Retrograde Cholangiopancreatography) - both diagnostic and therapeutic (sphincterotomy, stone extraction, stenting, brush cytology/biopsy).
PTC (Percutaneous Transhepatic Cholangiography)/PTBD - used when ERCP fails or is inaccessible (e.g., altered anatomy, hilar obstruction), and for percutaneous biliary drainage.
EUS (Endoscopic Ultrasound) - useful for small ampullary/pancreatic lesions and FNA biopsy.

5. Preoperative Preparation of the Jaundiced Patient

Jaundiced surgical patients are at higher risk of bleeding, sepsis, and renal failure. Key measures (Yamada's Textbook of Gastroenterology; Maingot's Abdominal Operations):

Correct coagulopathy: parenteral vitamin K, fresh frozen plasma if PT/INR remains deranged.
Hydration and renal protection: obstructive jaundice predisposes to hepatorenal syndrome/acute kidney injury (endotoxemia + reduced renal perfusion). IV fluids, avoid nephrotoxic drugs and contrast when possible, consider mannitol in select cases.
Prevent and treat cholangitis: prophylactic/therapeutic broad-spectrum antibiotics covering gram-negative and anaerobic organisms.
Preoperative biliary decompression (ERCP stent or PTBD) - considered selectively, e.g., before major hepatectomy in a jaundiced patient or pancreaticoduodenectomy with long-standing/severe jaundice, or if cholangitis needs to settle first. Routine preoperative drainage before pancreaticoduodenectomy for resectable disease is not standard, as trials show it may increase complications without improving outcomes (Bailey and Love's Short Practice of Surgery).
Nutrition: address malnutrition/malabsorption of fat-soluble vitamins (A, D, E, K).
Monitor blood glucose - biliary obstruction and pancreatic pathology can affect glycemic control.

6. Management of Obstructive Jaundice

Depends on cause, level of obstruction, and patient fitness:

Choledocholithiasis: ERCP with sphincterotomy and stone extraction, followed by (or combined with) laparoscopic cholecystectomy. If ERCP fails, surgical CBD exploration (choledochotomy with T-tube drainage) is an option.
Malignant distal obstruction (resectable): pancreaticoduodenectomy (Whipple's procedure) for periampullary/pancreatic head cancers; preop biliary drainage only if surgery is delayed or severe cholangitis/jaundice.
Malignant obstruction (unresectable/palliative): ERCP biliary stenting (plastic or self-expanding metal stent) or PTBD; surgical biliary-enteric bypass (choledochojejunostomy/hepaticojejunostomy) in select fit patients.
Benign strictures: endoscopic or percutaneous balloon dilation and stenting, or surgical biliary-enteric anastomosis if refractory.
Cholangitis: IV fluids, broad-spectrum antibiotics, and urgent biliary decompression (ERCP preferred) once the patient is stabilized - this is a surgical emergency if the patient develops Reynolds' pentad (suppurative cholangitis).

7. Complications of Obstructive Jaundice

Cholangitis / septicemia - ascending infection behind the obstruction.
Coagulopathy - vitamin K malabsorption -> bleeding risk, especially during surgery.
Hepatorenal syndrome / acute kidney injury - endotoxemia, reduced effective renal blood flow.
Impaired wound healing and immune dysfunction - due to malnutrition and bile salt effects on immune cells.
Pruritus and metabolic bone disease (in chronic cases) - malabsorption of vitamin D and calcium.
Cirrhosis / secondary biliary cirrhosis - with long-standing untreated obstruction.

8. Postoperative Jaundice (brief mention)

Jaundice appearing after surgery is a distinct differential surgeons must recognize, distinguishing it from the primary obstructive jaundice that prompted surgery:

Hemolysis (from transfused blood, prosthetic valves)
Drug-induced hepatotoxicity (anesthetic agents like halothane, antibiotics)
Sepsis-associated cholestasis
Benign postoperative intrahepatic cholestasis (multifactorial: hypotension, transfusion, sepsis)
Missed/retained stone or bile duct injury after biliary surgery

Quick recent-evidence check

I did not find contradictory recent systematic reviews/meta-analyses in this pass, this is a stable, well-established surgical topic; the core teaching (classification, Courvoisier's law, Charcot's triad, preop vitamin K, staged ERCP/PTBD/surgery) remains standard across current major surgical texts (Schwartz's, Current Surgical Therapy, Sabiston, Bailey and Love).

If you want, I can go deeper into any single piece next - e.g., a step-by-step exam-style "approach to a jaundiced patient" case, or a detailed writeup on pancreaticoduodenectomy (Whipple's) technique, or the ERCP vs PTBD decision algorithm.

This is a shared conversation. Sign in to Orris to start your own chat.